Eli Lilly's drive to provide as many treatment ... the launch of new high-dose vials sold at a $150 discount to its auto-injector versions. The company is adding 7.5mg and 10mg vials of Zepbound ...

A new daily weight-loss pill could be just as effective as the popular injectables that help patients lower their blood sugar and lose unwanted weight. "I think we're really at the beginning of a ...

Did Eli Lilly just say checkmate to Novo Nordisk? Well, an approval for an oral drug would represent a big victory. First, its likely many people would prefer a daily pill instead of an injection ...

Novo Nordisk and Eli Lilly currently dominate the weight-loss market, but their drugs are administered by injection. Both are working on pill versions that are seen as more convenient for patients ...

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient weight?loss pills. Investors will watch upcoming trial readouts and regulatory ...